{"id":"W1526927233","doi":"10.1056/nejmoa0802987","title":"Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7418,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"National Health and Medical Research Council; Medical Research Council; GW Pharmaceuticals; Gilead Sciences; Novo Nordisk; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Servier; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Hazard ratio; Glycated hemoglobin; Internal medicine; Type 2 diabetes; Retinopathy; Nephropathy; Diabetes mellitus; Diabetic retinopathy; Albuminuria; Incidence (geometry); Stroke (engine); Confidence interval; Endocrinology; Renal function","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}